Is Viveve Medical, Inc. (VIVE) a Buy, Sell, or Hold?
Viveve Medical, Inc.
NASDAQ:VIVE
$0.0002 USD
$0 (0.0%)
- Volume
- 47.93K
- Average Volume
- 7.82K
- Market Capitalization
- $4.29K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.04
- Year Low
- $0.00
- Payout Ratio
- $0.00
- Current Ratio
- $4.91
Industry, Sector & symbol
| Stock Exchange | NASDAQ Capital Market |
| CEO | Ms. Deborah Ann Jorn M.B.A. |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | VIVE |
| CUSIP | 92852W303 |
| CIK | 0000879682 |
| Web | https://www.viveve.com |
| Phone | 720 696 8100 |
| Currency | USD |
| Employees | 47 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.36 |
| Payout Ratio | 0.00 |
| Current Ratio | 4.91 |
| Quick Ratio | 4.58 |
| Cash Ratio | 4.23 |
Sales & Book Value
| Annual Sales | $6.43M |
| Price / Sales | 0.00 |
| Cash Flow | -1.32 |
| Price / Cash Flow | 0.00 |
| Price / Book | 0.00 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Buy |
| Rating Score(0-5) | 4 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-2.65 |
| Trailing P/E Ratio | 0.00 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-22.03M |
| Net Margin | -342.78% |
| Pretax Margin | -338.80% |
| Return on Equity | -199.88% |
| Return on Assets | -85.00% |
Financials Score
| AltmanZ Score | -35.14 |
| Piotroski Score | 4.00 |
| Working Capital | -1.23M |
| Total Assets | 12.15M |
| Ebit | -21.38M |
| Market Cap | 4.29K |
| Total Liabilities | 10.97M |
Poll Results
About Viveve Medical, Inc. (NASDAQ:VIVE) Stock
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. ...
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
2023-01-17 08:43:42
Viveve Medical (NASDAQ: VIVE ) stock is falling hard on Tuesday after releasing results from the company's latest clinical trial. That trial covers the use of the Viveve treatment for women suffering from stress urinary incontinence.
Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript
2022-11-10 21:25:04
Viveve Medical, Inc. (NASDAQ:VIVE ) Q3 2022 Results Conference Call November 10, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Scott Durbin - CEO Jim Robbins - SVP, Finance and Administration Operator Good afternoon. Welcome to the Viveve Third Quarter 2022 Financial Results and Corporate Update Conference Call.
2022-10-27 08:28:00
ENGLEWOOD, CO / ACCESSWIRE / October 27, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 10, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript
2022-08-11 18:38:04
Viveve Medical, Inc. (NASDAQ:VIVE ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - SVP, Finance and Administration Scott Durbin - CEO Conference Call Participants Operator Good afternoon, and welcome to the Viveve Second Quarter 2022 Financial Results and Corporate Update Conference Call. [Operator Instructions] Please note, this event is being recorded.
2022-07-28 16:28:00
ENGLEWOOD, CO / ACCESSWIRE / July 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 11, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Frequently Asked Questions
-
What is the current Viveve Medical, Inc. (VIVE) stock price?
-
Viveve Medical, Inc.(NASDAQ:VIVE) stock price is $0.0002 in the last trading session. During the trading session, VIVE stock reached the peak price of $4 while $1.0E was the lowest point it dropped to. The percentage change in VIVE stock occurred in the recent session was 0.0% while the dollar amount for the price change in VIVE stock was $0.
-
VIVE's industry and sector of operation?
-
The NASDAQ listed VIVE is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of VIVE?
-
Ms. Lori McMillan | Vice President of Human Resources
Mr. Jeff Sinclair | Vice President of International Sales
Mr. Jim B. Robbins CPA | Senior Vice President of Finance & Administration and Principal Accounting & Financial Officer
Mr. Martin Kerber P.E. | Vice President of Research, Development & Operations
Ms. Deborah Ann Jorn M.B.A. | Senior Advisor to the Chief Executive Officer & Director -
How many employees does VIVE have?
-
Number of VIVE employees currently stands at 47. VIVE operates from Building B, Englewood, CO 80112, US.
-
Link for VIVE official website?
-
Official Website of VIVE is: https://www.viveve.com
-
How do I contact VIVE?
-
VIVE could be contacted at phone #720 696 8100 and can also be accessed through its website. VIVE operates from Building B, Englewood, CO 80112, US.
-
How many shares of VIVE are traded daily?
-
The average number of VIVE shares traded daily for last 3 months was 7.82K.
-
What is the market cap of VIVE currently?
-
The market value of VIVE currently stands at $4.29K with its latest stock price at $0.0002